Abstract
Venous thromboembolism (VTE) is the third most common cardiovascular disease for which many clinical guidelines have been published in the Western world. In Japan, VTE has recently been recognized as a common disease and has received increased social as well as medical attention; however, the clinical diagnostic yield is still low. The most effective means of reducing unexpected death from VTE is to implement a comprehensive institutional policy of primary prophylaxis in patients at risk. Although it is difficult to prepare Japanese guidelines for prophylaxis of VTE based on reliable evidence, epidemiological information is available in the general surgical, orthopedic, and gynecological areas of practice. Finally, the first Japanese guidelines for prophylaxis of VTE were published in the spring of 2004. In addition, the diagnostic and management strategies have changed along with improvement in modalities and coverage by thrombolytic agents. The next goal is to gather evidence that provides the foundation for guidelines on treatment and prophylaxis. Large-scale research studies similar to those performed in the West should be conducted to elucidate the pathological mechanisms of VTE and improve its management.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Task Force on Pulmonary Embolism, European Society of Cardiology (2000) Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J 21:1301–1336
British Thoracic Society Standards of Care Committee Pulmonary Embolism Guideline Development Group (2003) British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax 58:470–483
Geerts WH, Pineo GF, Heit JA, et al (2004) Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126:338S–400S
Nicolaides AN, Breddin HK, Fareed J, et al (2001) Prevention of venous thromboembolism: international consensus statement-guidelines compiled in accordance with the scientific evidence. Int Angiol 20:1–37
Japanese Society of Pulmonary Embolism Research: JaSPER. URL http://jasper.gr.jp/
Nakano T, Goldhaber SZ (eds) (1999) Pulmonary embolism. Springer, New York
Kunio S (ed) (2005) Venous thromboembolism. Springer, Tokyo
Editorial Committee on Japanese Guideline for Prevention of Venous Thromboembolism (2004) Japanese guideline for prevention of venous thromboembolism. Medical Front International, Tokyo
Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (2004) Jpn Circ J 69:1077–1126
Gillum RF (1987) Pulmonary embolism and thrombophlebitis in the United States, 1970–1985. Am Heart J 114:1262–1264
Bell WR, Simon TL (1982) Current status of pulmonary thromboembolic disease: pathophysiology, diagnosis, prevention, and treatment. Am Heart J 103:239–262
Gore I, Hirst AE, Tanaka K (1964) Myocardial infarction and thrombosis. Arch Intern Med 113:323–330
Hasegawa H, Nagata H, Yamauchi M, et al (1981) Statistical status of pulmonary embolism in Japan (II). Jpn J Chest Dis 40:677–681 (in Japanese)
Mieno T, Kitamura S (1989) Incidence of pulmonary thromboembolism in Japan. Kokyu to Junkan 37:923–927 (in Japanese)
Kitajima I, Tachibana S, Hirota Y, et al (1999) The incidence of pulmonary embolism following total hip arthroplasty. Seikei Geka 50:1287–1290 (in Japanese)
Fujita S, Fuji T, Mitsui T, et al (2000) Prospective multicenter study on prevalence of deep vein thrombosis after total hip or total knee arthroplasty. Seikei Geka 51:745–749 (in Japanese)
Mizukami Y, Murai Y, Fukushima Y, et al (1976) Pulmonary thromboembolism in a sequent autopsy series of 200 elders. Kokyu to Junkan 24:979–984 (in Japanese)
Ito S (1982) Clinico-pathological studies on pulmonary thromboembolism. Mie-Igaku 25:586–597 (in Japanese)
Ito M (1991) Pathology of pulmonary embolism. Kokyu to Junkan 39:567–572
Nakamura Y, Yutani C, Imakita M, et al (1996) Pathophysiology of clinicopathological aspect of venous thrombosis and pulmonary thromboembolism. Jpn J Phlebol 7:17–22 (in Japanese)
Kumasaka N, Sakuma M, Shirato K (1999) Incidence of pulmonary thromboembolism in Japan. Jpn Circ J 63:439–441
Kitamukai O, Sakuma M, Takahashi T, et al (2003) Incidence and characteristics of pulmonary thromboembolism in Japan 2000. Intern Med 42:1090–1094
Thomas WA, Davies JNP, O’Neal RM, et al (1960) Incidence of myocardial infarction correlated with venous and pulmonary thrombosis and embolism: a geographic study based on autopsies in Uganda, East Africa and St. Louis, USA. Am J Cardiol 5:4–47
Joffe SN (1974) Racial incidence of postoperative deep vein thrombosis in South Africa. Br J Surg 61:982–983
Dahlback B, Carlsson M, Svensson PJ (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A 90:1004–1008
Seki T, Okayama H, Kumagai T, et al (1998) Arg506Gln mutation of the coagulation factor V gene not detected in Japanese pulmonary thromboembolism. Heart Vessels 13:195–198
Ro A, Hara M, Takada A (1999) The factor V Leiden mutation and the prothrombin G20210A mutation was not found in Japanese patients with pulmonary thromboembolism. Thromb Haemost 82:1769
White RH, Zhou H, Romano PS (1998) Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med 128:737–740
Klatsky AL, Armstrong MA, Poggi J (2000) Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol 85:1334–1337
Yamada N, Nakamura M, Ishikura K (2003) Epidemiological characteristics of acute pulmonary thromboembolism in Japan. Int Angiol 22:50–54
Lilienfeld DE (2000) Decreasing mortality from pulmonary embolism in the United States, 1979–1996. Int J Epidemiol 29:465–469
Sakuma M, Konno Y, Shirato K (2002) Increasing mortality from pulmonary embolism in Japan, 1951–2000. Circ J 66:1144–1149
Sakuma M, Takahashi T, Kitamukai O, et al (2002) Incidence of pulmonary embolism in Japan: analysis using “Annual of the pathological autopsy cases in Japan.” Ther Res 23:632–634
Nakamura M, Fujioka H, Yamada N, et al (2001) Clinical characteristics of acute pulmonary thromboembolism in Japan: results of a multicenter registry in the Japanese Society of Pulmonary Embolism Research. Clin Cardiol 24:132–138
Sakuma M, Nakamura M, Nakanishi N, et al (2004) Inferior vena cava filter is a new additional therapeutic option to reduce mortality from acute pulmonary embolism. Circ J 68:816–821
Ota M, Nakamura M, Yamada N, et al (2002) Prognostic significance of early diagnosis in acute pulmonary thromboembolism with circulatory failure. Heart Vessels 17:7–11
Sakuma M, Okada O, Nakamura M, et al (2003) Recent developments in diagnostic imaging techniques and management for acute pulmonary embolism: multicenter registry by the Japanese Society of Pulmonary Embolism Research. Intern Med 42: 470–476
Nakamura M, Nakanishi N, Yamada N, et al (2005) Effectiveness and safety of the thrombolytic therapy for acute pulmonary thromboembolism: results of a multicenter registry in the Japanese Society of Pulmonary Embolism Research. Int J Cardiol 99:83–89
Wan S, Quinlan DJ, Agnelli G, et al (2004) Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation 110:744–749
Konstantinides S, Geibel A, Heusel G, et al (2002) Management strategies and prognosis of Pulmonary Embolism-3 Trial investigators: heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 347:1143–1150
Yamada N, Ishikura K, Ota S, et al (2006) Pulse-spray pharmacomechanical thrombolysis for proximal deep vein thrombosis. Eur J Vasc Endovasc Surg 31:204–211
Yazu T, Fujioka H, Nakamura M, et al (2000) Long-term results of inferior vena cava filters: experiences in a Japanese population. Intern Med 39:707–714
Decousus H, Leizorovicz A, Parent F, et al (1998) A clinical trial of vena cava filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med 338:409–415
Yamada N, Niwa A, Sakuma M, et al (2001) Status of use of temporary vena cava filters in Japan. Ther Res 22:1439–1441 (in Japanese)
Ishikura K, Yamada N, Oota M, et al (2002) Clinical experience with retrievable vena cava filters for prevention of pulmonary thromboembolism. J Cardiol 40:267–273 (in Japanese)
Samama MM, Cohen AT, Darmon JY, et al (1999) A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients: prophylaxis in medical patients with Enoxaparin Study Group. N Engl J Med 341: 793–800
Eriksson BI, Bauer KA, Lassen MR, et al (2001) Steering Committee of the Pentasaccharide in Hip-Fracture Surgery Study: fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med 345:1298–1304
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer
About this chapter
Cite this chapter
Nakamura, M. et al. (2008). Current Clinical Status of Venous Thromboembolism in Japan. In: Tanaka, K., Davie, E.W., Ikeda, Y., Iwanaga, S., Saito, H., Sueishi, K. (eds) Recent Advances in Thrombosis and Hemostasis 2008. Springer, Tokyo. https://doi.org/10.1007/978-4-431-78847-8_38
Download citation
DOI: https://doi.org/10.1007/978-4-431-78847-8_38
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-78846-1
Online ISBN: 978-4-431-78847-8
eBook Packages: MedicineMedicine (R0)